News

The partners will use Cellino's autonomous biomanufacturing tech to produce high-quality autologous iPSCs for Karis' ...
About Troculeucel Troculeucel is a novel cell-based, patient specific, ex vivo expanded autologous NK cell immunotherapeutic drug candidate. NKGen is developing troculeucel for the treatment of ...
Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...
Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...
Most nasal lymphomas in these populations are of NK-cell lineage ... The role of autologous and allogeneic hematopoietic stem-cell transplantation should be established by controlled trials.
The donation itself only takes 10 minutes — a small fraction of your day that could literally save someone’s life. Canadian Blood Services operates a national system for blood, plasma, and stem cell ...
The blood bags made by Vogt Medical are suitable for blood collection (autologous blood donation) and for storage of various blood products (platelet concentrates).